Zurbuchen Urte, Groene Joern, Otto Susanne D, Kreis Martin E, Maerzheuser Stefanie
Department of General, Visceral, and Vascular Surgery, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany,
Int J Colorectal Dis. 2014 Oct;29(10):1297-302. doi: 10.1007/s00384-014-1942-7. Epub 2014 Jul 5.
The aim of this study was to evaluate both the feasibility and effectiveness of sacral neuromodulation for fecal incontinence and constipation in adult patients who had undergone surgical repair of anorectal malformations (ARM).
Patients with ARM with or without sacral dysgenesis who presented with fecal incontinence, constipation, or combined symptoms were treated with sacral nerve stimulation (SNS). Success of SNS was assessed by scores preoperatively and after a 3-week test period: Cleveland Clinic Incontinence Score (CCI), Surgical Working Group for Coloproctology (CACP) continence score, German version of the Fecal Incontinence Quality of Life Scale, and Cleveland Clinic Constipation Score (CCCS). The follow-up results of the patients who received a definitive pacemaker were used to evaluate the long-term effect of SNS in patients with ARM.
Four patients with fecal incontinence and one patient with constipation (two males, three females; median age 24 years [13; 31]) were treated with SNS between May 2012 and May 2013. Four patients had a normal sacrum; one patient had a sacral dysgenesis. Preoperatively and after the test phase, median CACP continence scores were 8 [1; 10] and 11.5 [3; 16], median CCI 14 [12; 19] and 13 [11; 17], and median Fecal Incontinence Quality of Life Scale improved in all categories. For constipation, CCCSs were 16 and 7.
Sacral neuromodulation is a feasible treatment modality for adult patients with ARM with a normally developed sacrum. Patients with sacrum dysgenesis are not suited for SNS because a definitive quadripolar electrode could not be anchored in the absence of a sacral bone.
本研究旨在评估骶神经调节对成年直肠肛门畸形(ARM)手术修复术后出现大便失禁和便秘患者的可行性和有效性。
对出现大便失禁、便秘或合并症状的伴有或不伴有骶骨发育不全的ARM患者进行骶神经刺激(SNS)治疗。通过术前和3周测试期后的评分评估SNS的效果:克利夫兰诊所失禁评分(CCI)、结直肠外科学术工作组(CACP)失禁评分、德语版大便失禁生活质量量表以及克利夫兰诊所便秘评分(CCCS)。采用接受永久性起搏器植入患者的随访结果评估SNS对ARM患者的长期疗效。
2012年5月至2013年5月期间,对4例大便失禁患者和1例便秘患者(2例男性,3例女性;中位年龄24岁[13;31])进行了SNS治疗。4例患者骶骨正常;1例患者有骶骨发育不全。术前和测试期后,CACP失禁评分中位数分别为8[1;10]和11.5[3;16],CCI中位数分别为14[12;19]和13[11;17],且大便失禁生活质量量表各分类的中位数均有所改善。对于便秘患者,CCCS分别为16和7。
对于骶骨发育正常的成年ARM患者,骶神经调节是一种可行的治疗方式。骶骨发育不全的患者不适合SNS,因为在没有骶骨的情况下无法固定永久性四极电极。